Skip to main content
International Journal of Reproductive Biomedicine logoLink to International Journal of Reproductive Biomedicine
. 2019 Jul 31;17(7):463–472. doi: 10.18502/ijrm.v17i7.4857

The relationship between body mass index and preeclampsia: A systematic review and meta-analysis

Morteza Motedayen 1, Mohammad Rafiei 2, Mostafa Rezaei Tavirani 3, Kourosh Sayehmiri 4, Majid Dousti 4
PMCID: PMC6718883  PMID: 31508571

Abstract

Background

One of the causes of maternal and fetal mortality and morbidity is pregnancy-induced hypertension, the most common form of which is preeclampsia that causes many complications for mother and fetus.

Objective

The aim of this systematic review and meta-analysis was to determine the relationship between body mass index (BMI) and preeclampsia in Iran.

Materials and Methods

Using valid keywords in the SID database, PubMed, Scopus, data obtained from all the articles, which were reviewed in Iran between 2000 and 2016, were combined using the meta-analysis method (random-effects model) and analyzed using STATA version 11.1.

Results

A total number of 5,946 samples were enrolled in 16 studies with the mean BMI values of 25.13, 27.42, and 26.33 kg /m2 in the healthy, mild, and severe preeclamptic groups, respectively.

Conclusion

The results of this study revealed that there is a significant relationship between BMI and the risk of preeclampsia, so it can be said that BMI may be one of the ways to diagnose preeclampsia.

Keywords: Preeclampsia, Body mass index, Iran, Meta-analysis.

1. Introduction

Preeclampsia is a pregnancy-related disease that increases maternal and perinatal mortality and morbidity (1, 2). The possible causes of preeclampsia include abnormal vascular thromboembolic invasion, lack of maternal-fetal immune tolerance and maternal maladaptation with cardiovascular and inflammatory changes during pregnancy and genetics (3). Preeclampsia affects 5–8% of all pregnancies (4) and causes many complications for mother and fetus in such a way that 50,000 women worldwide die from preeclampsia and its complications annually (5). Researchers believe that preeclampsia is a multifactorial disease and propose several risk factors for it, including a history of preeclampsia, low and high maternal age, diabetes, chronic hypertension, null parity, birth intervals, history of abortion, high body mass index (BMI) value, twin pregnancy, fetal sex, migraine, and maternal RH (6-10). A major part of the complications and some of the risk factors proposed for this disorder can be identified and prevented. Although the termination of pregnancy is considered as a definitive treatment of preeclampsia, careful prenatal care and appropriate treatment can improve the condition, and the outcome can be satisfactory for the mother and fetus in many cases (11). Some studies have referred to obesity as a risk factor for preeclampsia and showed that the relationship between maternal weight and preeclampsia is a progressive risk and varies from 4.3% in women with a BMI < 19.8 Kg/m2, up to 13.3% for women with a BMI 35 kg/m2 (12).

Since the objectives of meta-analysis include regular and systematic review of the evidence, the quantitative summing up of the results of each study, combining the results of various studies and providing a general interpretation of the results (13), the aim of the present study was to investigate the relationship between the maternal BMI and preeclampsia using the by meta-analysis technique, performing more studies in this area, and reducing neonatal morbidity and mortality.

2. Materials and Methods

The present study was carried out using the meta-analysis technique and random-effects models. It was conducted in several steps to accurately determine the problem under study and collecting, analyzing, and interpreting the findings and using preferred reporting items for systematic reviews and meta-analyses (PRISMA). The study began after using the aforementioned protocol as a research criterion as well as identifying the members of the meta-analysis group (including the group's supervisor and the final reviewer, the group's advisor, reviewer, and researcher; data extractor and collector; and article explorer). To review the studies, SID, Scopus, and PubMed databases were first systematically searched using valid Persian keywords (preeclampsia, BMI, pregnancy) and valid English keywords (preeclampsia, BMI, and pregnancy) in order to identify and evaluate the studies on the prevalence of preeclampsia in pregnant women in Iran. The studies were later classified as case-controls.

Selection of studies and data extraction

All articles related to preeclampsia were collected and a list of articles' abstract was later prepared after the completion of the search. Then all articles, in which the BMI value was specified, were included in the first list.

Then, quality assessment was done by the Newcastle-Ottawa Scale. The adjusted Ottawa checklist was used to evaluate the quality of the studies. In this case, three subsets of the groups (four questions), group comparability (one question), and exposure or outcome (two questions) are examined (14), this tool is usually used for Validity assessment and is a reliable instrument with a long history of reliability (15).

Studies with a score of 3 or more were considered qualitative and entered into the analysis. Other studies that addressed preeclampsia, causes of preeclampsia, ways to cope with preeclampsia, and risk factors for preeclampsia in pregnant women were excluded from the list. A necessary information checklist containing the researcher's name, article's title, year of conducting the research, research setting, code of the research setting, age group, sample size, BMI, etc., were prepared for all studies that underwent the initial evaluation in order to undergo the final evaluation. Finally, the final checklist was reviewed and the relevant articles were entered into the meta-analysis. According to these steps, 101 articles were found using the keywords in the first search. After the analysis phase, 16 appropriate articles entered the meta-analysis phase (Figure 1, Table I).

Table 1.

Specifications of the studies performed


Researcher Year of study implementation Sample size Type of study Average age group of participants BMI in healthy group 95% CI (BMI in the healthy group) BMI in mild PE group 95% CI (BMI in the mildly affected group) BMI in the severe affected group 95% CI (BMI in the severe affected group)
16 2007 200 Case-control 26.88 24 23.17–24.73 26 25.72–26.28 26 24.86–27.14
17 2012 498 Case-control 29.01 25.91 25.27–26.55 28.99 27.63–30.35 26.29 25.31–27.27
18 2007 400 Case-control 23.19 26.24 25.97–26.51 29.93 28.21–31.65
19 2012 112 Case-control 24.94 23.60 22.68–24.52 22.39 20.43–24.35
20 2010 675 Case-control 32.85 21.05 21.15
21 2006 636 Case-control 27 23
22 2010 610 Case-control 22.85 20
23 2013 90 Case-control 27.3 25.30 24.57–26.03 25.90 25.02–26.78
24 2009 187 Case-control 25.81 23.25 23.01–23.49 23.47 23.19–23.75
25 2008 64 Case-control 26.37 29.14 28.96–29.32 30.35 30.14–30.56
26 2010 60 Case-control 31.67 21.95 21.77–22.13 23.65 23.38–23.92
27 2001 674 Case-control 24.4 24.20 23.61–24.79 24 23.61–24.39
28 2010 60 Case-control 31.51 26.74 26.59–26.89 27.61 27.44–27.78
29 2006 80 Case-control 23.7 12.41 12.61
30 2010 1200 Case-control 28.11 25.45 28.56
BMI: Body mass index

Figure 1.

Figure 1

Flowchart of the stages of the systematic review and meta-analysis.

Inclusion and exclusion criteria

Inclusion criteria included access to the full text of the article, English or Persian, articles aimed at examining the relationship between the components studied. Exclusion Criteria included unrelated articles, the inaccessibility of the full text of the article, and the incomplete abstract of the article. All analyzes were performed in this study using STATA according to the critical evaluation criteria and the eligible articles were included in the study.

Statistical analysis

Considering that the main index studied in this review study was BMI, its variance was calculated by the binomial distribution, and the odd ratio with a 95% confidence interval (CI) was calculated. The weighted average was used to combine the rates obtained from different studies. Each study was weighted inversely in proportion to its variance. The heterogeneity was evaluated using Q test and I2 at the given significance level (α < 10%). Data analysis was performed using the meta-analysis technique (random-effects model) in cases of any heterogeneity. Data analysis was carried out using R and STATA Version 11.2.

3. Results

In the present study, a total of 16 articles which were published between 2000 and 2016 were reviewed and the total sample size was 5,946 women. The mean BMI was 25.13 (95% CI: 23.52-2.74) (Figure 2), 27.42 kg (95% CI: 24.4-30.34), (Figure 3), and 26.33 kg/m2 (95% CI: 24.52-28.13) (Figure 4) in the healthy, mild, and severe PE groups, respectively. As seen in Table II, the mean maternal age in the healthy and affected groups was 26.21 and 28.20 years, respectively, which indicates the effect of age on the disorder, considering the studied variable (BMI); however, this relationship was not significant. Also, the mean systolic and diastolic blood pressure was 142.75, 99.26 and 101.59, 70.76 mmHg in the affected and healthy groups, respectively, which indicates a direct relationship between hypertension and preeclampsia. These results revealed that hypertension is somewhat associated with an increase in BMI. Also, the average week of pregnancy in the healthy and affected mothers is 34.15 and 33.82 weeks, respectively, which seems to indicate no specific relationship between individuals with preeclampsia and BMI with the average week of pregnancy.

According to the publication bias figure, Beggs test showed that the effect of bias in these studies was significant. (p = 0.584) (Figure 5).

Table 2.

The mean of variables in the studies


Variables Number of study 95% confidence interval
Healthy group 13 26.21 (24.04-28.38)
Mean age of pregnant mothers Affected group 2 28.20 (26.61-29.80)
Healthy mothers 5 101.59 (96.60-106.58)
Mean systolic blood pressure Affected mothers 5 142.75 (132.12-153.38)
Healthy mothers 7 70.76 (65.87-75.65)
Mean diastolic blood pressure Affected mothers 7 99.26 (91.74-106.79)
Healthy mothers 8 34.15 (37.16-31.15)
Mean week of pregnancy Affected mothers 8 33.82 (30.67-36.96)
Healthy mothers 2 159.14 (157.04-161.24)
Mean maternal height (in cm) Affected mothers 2 159.19 (157.90-160.47)
Healthy mothers 2 3094.39 (2837.84-3350.92)
Mean maternal weight (gr) Affected mothers 2 2508 (1903.35-3113.83)
Healthy mothers 11 25.13 (23.52-26.74)
Affected mothers (mild) 2 27.42 (24.49-30.34)
<brow>-3</erow> Mean BMI Affected mothers (severe) 11 26.33 (24.52-28.13)
Healthy mothers 8 34 (31-37)
Mean pregnancy week Affected mothers 8 33 (30-37)
Healthy mothers 5 101.50 (96.6-106.58)
Mean blood pressure systolic Affected mothers 5 147.75 (132.12-153.38)
Healthy mothers 7 56.24 (32.36-80.12)
Mean blood pressure diastolic 8 Affected mothers 7 81.49 (64.03-98.95)

Figure 2.

Figure 2

BMI in healthy pregnant women, by year, prevalence rate, and 95% CI interval. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI.

Figure 3.

Figure 3

The BMI value in pregnant women with mild PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI.

Figure 4.

Figure 4

The BMI value in pregnant with severe PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI.

Figure 5.

Figure 5

Beggs Funnel plot for publication bias.

4. Discussion

In this study, the average age of the mothers was 21.26 years in the healthy group and 20.28 years in the affected mothers. The average height of mothers was 159.14 cm in the healthy group and 159.19 cm in the affected group. Finally, the mean value of BMI was 25.13% in the healthy group and 26.33% in the (severely) affected group. The highest BMI in the healthy pregnant women was 29.14% and the lowest one was 21.95%. Furthermore, the highest BMI in the pregnant women with preeclampsia was 30.35% and the lowest was 22.39%. Moreover, in this study, the general prevalence of preeclampsia (severe) was 7% and the general prevalence of preeclampsia (mild) was obtained as 23%. The mean systolic hypertension in the studied group was 142.75 mmHg, while that of the healthy group was 101.59 mmHg, and the mean diastolic hypertension was 99.26 mmHg in the affected group and 70.76 mmHg in the healthy mothers.

According to the results obtained earlier, it can be concluded that the relationship between age and the incidence of intended disorder considering BMI was not significant. Further, there is no specific relationship between those with preeclampsia and BMI with the mean of gestational age.

Hypertension has a direct relationship with preeclampsia. According to these results, it can be concluded that hypertension is one of the factors that increases BMI in pregnant women. Additionally, high BMI has a relationship with preeclampsia in pregnant women. This result is relatively consistent with Brown's study; in the Brown's study, the percentage of preeclampsia prevalence (4.5%) in women with light weight is approximately half of the women with normal weight (0.09) (31).

In a study by Vahid Roodsari et al. BMI was reported to be 24 kg/m2 in the pre-pregnancy control group, 26.124 kg/m2 in the gestational hypertension group, 26.24 kg/m2 in the group with mild preeclampsia and 26.24 kg/m2 in the severe preeclampsia group. It has been reported (32), according to the obtained results, that if weight increases before pregnancy, weight loss will prevent mortality during pregnancy. Jang et al. in Seoul, Korea, compared two groups and showed that the incidence of preeclampsia in women with overweight women is higher than those of normal weight (33). Derif et al. also stated that hypertension problems occurs more in overweight women indicating its incidence 7% to 17% (34). Kramer, in a researcher at the University of New York, found that as the BMI increases among the mothers, the risk of cesarean operation will increase significantly (35).

In the study by Ohkuchi et al. the incidence of hypertension during pregnancy in women with less weight, normal weight, weight more than normal, and obese was 1.1%, 1.8%, 5.8%, and 19.6%, respectively, which besides its consistency with the results of this study, indicates that the incidence of pre-pregnancy hypertension in obese women significantly increases (36). Sibai also reported in a study that high weight before pregnancy is an important risk factor for pregnancy toxicity (37). These results are relatively consistent with the conducted study. In addition, in a study by Bondar in the United States, it was shown that 56% of women with gestational toxicity were suffering from either overweight or obesity, and every 4-unit increase in BMI was related to twice the risk of gestational toxicity and an 8-unit increase in BMI was related to three times the risk of gestational toxicity (38). In another study by Belogolovkin et al. in the United States, it was concluded that the probability of a pregnancy-related hypertention in women with a high BMI (26.1-29 kg/m2) was 6%, whereas in women with a normal BMI (19.86-26 kg/m2) it was 3.2%, and the probability of pregnancy toxicity in women with normal BMI is 1.9%, whilein women with a high BMI, it was 2.8% (39).

Cogswell and Yip, in the United States, showed that women with high BMI have more deliveries (40). In the conducted study also women with heavy weight had more deliveries.

Naevy et al., found that the prenatal mortality was higher in women with heavy weight than other groups, and it is said that the reason behind it lies in the increased multiple pregnancy and preterm birth (41).

Women with high BMI have adverse effects of pregnancy, delivery, and neonate, and even in the pre-pregnancy period; women with abnormal weight face with problems such as polycystic ovary, infertility, and failure in infertility treatments (41). Pregnant women with abnormal weight and obesity are subject to the risk of diabetes mellitus type 2, gestational diabetes, and preeclampsia (42), thromboembolic diseases (43), dyspnea (44), asthma (45), cholecystitis (46), back pain, pelvic pain (47) and urinary incontinence (48).

Problems regarding data extraction

Among the problems we encountered during the data extraction in this article were the irrelevancy of the article to the stated subject, the inaccessibility of the full text of the article, and the incomplete information given in the abstract part of the article. The control of all discomfit factors was not possible, and factors such as diet are effective factors that have not been measured in studies.

5. Conclusion

This meta-analysis study, in which BMI was evaluated, showed that the risk of preeclampsia may increase with an increase in BMI. Therefore, BMI can be considered as one of the ways to diagnose the preeclampsia.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

  • 1.Cuningham F., Leveno K., Bloom S., Hauth J., Gilstrap L., Katharine W. Williams Obstetrics. 22th. New York: Mccraw-Hill; 2005. Williams obstetrics; p. 768. [Google Scholar]
  • 2.Ferrazzani S., Caruso A., De Carolis S., Martino I. V., Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. American Journal of Obstetrics & Gynecology. 1990;162(2):366–371. doi: 10.1016/0002-9378(90)90387-M. [DOI] [PubMed] [Google Scholar]
  • 3.Cunnigham FG., Gant NF., Leveno KJ., Larry C. Obstetrics. Journal of Midwifery Womens Health. 2010:48–369. [Google Scholar]
  • 4.Shah S., Gupta A. Gupta A. Hypertensive disorders of pregnancy. Cardiol Clin. Vol. 37. 37: 345-354; 2019. Hypertensive disorders of pregnancy. Cardiol Clin; pp. 345–354. [DOI] [PubMed] [Google Scholar]
  • 5.Broughton Pipkin F. Risk factors for preeclampsia: Editorial. The New England Journal of Medicine. 2001;344(12):925–926. doi: 10.1056/NEJM200103223441209. [DOI] [PubMed] [Google Scholar]
  • 6.Trogstad L., Magnus P., Stoltenberg C. Pre-eclampsia: Risk factors and causal models. Best Practice & Research Clinical Obstetrics & Gynaecology. 2011;25(3):329–342. doi: 10.1016/j.bpobgyn.2011.01.007. [DOI] [PubMed] [Google Scholar]
  • 7.Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal. 2005;330(7491):565. doi: 10.1136/bmj.38380.674340.e0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Khalil M. M., Alzahra E. Fetal gender and pregnancy outcomes in Libya: a retrospective study. Libyan Journal of Medicine. 2013;8(1):20008. doi: 10.3402/ljm.v8i0.20008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Facchinetti F., Allais G., D’Amico R., Benedetto C., Volpe A. The relationship between headache and preeclampsia: a case–control study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2005;121(2):143–148. doi: 10.1016/j.ejogrb.2004.12.020. [DOI] [PubMed] [Google Scholar]
  • 10.Alpoim P. N., de Barros Pinheiro M., Junqueira D. R., Freitas L. G., das Graças Carvalho M., Fernandes A. P., Komatsuzaki F., Gomes K. B., Dusse L. M. Preeclampsia and ABO blood groups: a systematic review and meta-analysis. Molecular Biology Reports. 2013;40(3):2253–2261. doi: 10.1007/s11033-012-2288-2. [DOI] [PubMed] [Google Scholar]
  • 11.Dekker GA. Management of preeclampsia. Pregnancy Hypertens. Vol. 4. 4: 246-247; 2014. [DOI] [PubMed] [Google Scholar]
  • 12.Phipps E., Prasanna D., Brima W., Jim B. Preeclampsia: Updates in pathogenesis, definitions, and guidelines. Clinical Journal of the American Society of Nephrology. 2016;11(6):1102–1113. doi: 10.2215/CJN.12081115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Townsend R., O’Brien P., Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integrated Blood Pressure Control. 2016;9:79–94. doi: 10.2147/IBPC.S77344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Herzog R., Álvarez-Pasquin M. J., Díaz C., Del Barrio J. L., Estrada J. M., Gil Á. Are healthcare workers intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13(1):113–154. doi: 10.1186/1471-2458-13-154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Luchini C., Stubbs B., Solmi M., Veronese N. Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale. World Journal of Meta-Analysis. 2017;5(4):80. doi: 10.13105/wjma.v5.i4.80. [DOI] [Google Scholar]
  • 16.Vahidrodesari F., Ayati S., Ebrahimi M., Esmaili H., Shahabian M. Shahabian M. [The effect of prepregnancy body mass index on the development of gestational hypertension and preeclampsia.] J Babol Uni Sci. Vol. 11. 11: 49-53. (in Persian; 2009. [The effect of prepregnancy body mass index on the development of gestational hypertension and preeclampsia.] J Babol Uni Sci; pp. 49–53. in Persian. [Google Scholar]
  • 17.Sharemi S. H., Milani F., Zahiri Z., Zendedel M., Salamat F., Rafipour B., Javid Z. Comparison of pre-eclampsia risk factors regarding to its severity in pregnant women referred to Alzahra hospital of Rasht, Iran, 2012. Iranian Journal of Obstetrics, Gynecology and Infertility. 2013;16(69):1–8. [Google Scholar]
  • 18.Fathnejad Kazemi A., Sehati Shafaie F., Sattarzadeh N., Ebrahimi Mamaghani M. [Predictive value of roll-over test and BMI in early diagnosis of pre eclampsia.] J Ardabil Univ Med Sci. 2008;8:414–419. in Persian. [Google Scholar]
  • 19.Abedi P., Mohaghegh Z., Afshary P., Latifi M. The relationship of serum vitamin D with pre-eclampsia in the Iranian women. Maternal & Child Nutrition. 2014;10(2):206–212. doi: 10.1111/mcn.12058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Abhari Farideh Rezaei, Ghanbari Andarieh Maryam, Farokhfar Asadollah, Ahmady Soleiman. Estimating Rate of Insulin Resistance in Patients with Preeclampsia Using HOMA-IR Index and Comparison with Nonpreeclampsia Pregnant Women. BioMed Research International. 2014;2014 doi: 10.1155/2014/140851.140851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kashanian M., Baradaran H. R., Bahasadri S., Alimohammadi R. Risk factors for pre-eclampsia: A study in tehran, Iran. Archives of Iranian Medicine. 2011;14(6):412–415. [PubMed] [Google Scholar]
  • 22.Direkvand-Moghadam A., Khosravi A., Sayehmiri K. Predictive factors for preeclampsia in pregnant women: a Receiver Operation Character approach. Archives of Medical Science. 2013;4:684–689. doi: 10.5114/aoms.2013.36900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Salimi Saeedeh, Farajian-Mashhadi Farzaneh, Naghavi Anoosh, Mokhtari Mojgan, Shahrakipour Mahnaz, Saravani Mohsen, Yaghmaei Minoo. Different Profile of Serum Leptin between Early Onset and Late Onset Preeclampsia. Disease Markers. 2014;2014 doi: 10.1155/2014/628476.628476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ranjkesh F., Abotorabi Sh., Kajinebaf J., Abbasi F. AbbasiF. [Assessment of the Level of copper in serum and 24-hour urine in pre-eclamptic pregnant women.]J Ardabil Univ Med Sci. Vol. 10. 10: 303-309. (in Persian; 2010. [Assessment of the Level of copper in serum and 24-hour urine in pre-eclamptic pregnant women.]J Ardabil Univ Med Sci; pp. 303–309. in Persian. [Google Scholar]
  • 25.Sharifzadeh F., Kashanian M., Fatemi F. A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy. Gynecological Endocrinology. 2012;28(10):834–836. doi: 10.3109/09513590.2012.683061. [DOI] [PubMed] [Google Scholar]
  • 26.Khosrowbeigi A., Lorzadeh N., Ahmadvand H. [Serum concentration of leptin and adiponectin in preeclampsia.] Scientific Journal. 2010;18:27–34. [Google Scholar]
  • 27.Nation K., Snowling M. J. Beyond phonological skills: broader language skills contribute to the development of reading. Journal of Research in Reading. 2004;27(4):342–356. doi: 10.1111/j.1467-9817.2004.00238.x. [DOI] [Google Scholar]
  • 28.Khosrowbighi A., Ahmadvand H. Ahmadvand H. Evaluation of total antioxidant capacity in pregnant women with preeclampsia. IJOGI. Vol. 16. 16: 1-5; 2013. Evaluation of total antioxidant capacity in pregnant women with preeclampsia. IJOGI; p. 1. [Google Scholar]
  • 29.Ghorashi V., Sheikhvatan M. The relationship between serum concentration of free testosterone and pre-eclampsia. Endokrynologia Polska. 2008;59(5):390–392. [PubMed] [Google Scholar]
  • 30.Taebi M., Sadat Z., Saberi F., Kalahroudi M. A. Early pregnancy waist-to-hip ratio and risk of preeclampsia: a prospective cohort study. Hypertension Research. 2015;38(1):80–83. doi: 10.1038/hr.2014.133. [DOI] [PubMed] [Google Scholar]
  • 31.Brown J. E., Jacobson H. N., Askue L. H., Peick M. G. Influence of pregnancy weight gain on the size of infants born to underweight women. Obstetrics & Gynecology. 1981;57(1):13–17. [PubMed] [Google Scholar]
  • 32.Vahidrodsari F., Ayati S., Ayatollahi H., Shahabian M., Ismail H. [Comparison of serum ceruloplasmin levels in normal pregnancy and preeclampsia.] Journal of Medical Council of Islamic Republic of Iran. 2009;27:437–442. in Persian. [Google Scholar]
  • 33.Jang HC., Cho NH., Min YK., Han IK., Jung KB., Metzger BE. Incrased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in korean women with GDM. Vol. 20. Diabetes Care; 1997. Incrased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in korean women with GDM; pp. 1582–1588. [DOI] [PubMed] [Google Scholar]
  • 34.Drife J. O. Weight gain in pregnancy: eating for two or just getting fat? BMJ. 1986;293(6552):903–904. doi: 10.1136/bmj.293.6552.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kramer M. S. Intrauterine growth and gestational duration determinants. Pediatrics. 1987;80(4):502–511. [PubMed] [Google Scholar]
  • 36.Ohkuchi A., Iwasaki R., Suzuki H., Hirashima C., Takahashi K., Usui R., Matsubara S., Minakami H., Suzuki M. Normal and high-normal blood pressure but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study. Hypertension Research. 2006;29(3):161–167. doi: 10.1291/hypres.29.161. [DOI] [PubMed] [Google Scholar]
  • 37.Sibai BM., Gordon T., Thom E., Caritis SN., Klebanoff M., McNellis D. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obster Gynecol. 1995:172–642. doi: 10.1016/0002-9378(95)90586-3. [DOI] [PubMed] [Google Scholar]
  • 38.Bodnar L. M., Ness R. B., Markovic N., Roberts J. M. The Risk of Preeclampsia Rises with Increasing Prepregnancy Body Mass Index. Annals of Epidemiology. 2005;15(7):475–482. doi: 10.1016/j.annepidem.2004.12.008. [DOI] [PubMed] [Google Scholar]
  • 39.Belogolovkin V., Eddleman K. A., Malone F. D., Sullivan L., Ball R. H., Nyberg D. A., Comstock C. H., Hankins G. D., Carter S., Dugoff L., Craigo S. D., Timor-Tritsch I. E., Carr S. R., Wolfe H. M., D'Alton M. E. The effect of low body mass index on the development of gestational hypertension and preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine. 2009;20(7):509–513. doi: 10.1080/14767050701420027. [DOI] [PubMed] [Google Scholar]
  • 40.Cogswell M. E., Yip R. The influence of fetal and maternal factors on the distribution of birthweight. Seminars in Perinatology. 1995;19(3):222–240. doi: 10.1016/S0146-0005(05)80028-X. [DOI] [PubMed] [Google Scholar]
  • 41.Naeye R. L. Maternal body weight and pregnancy outcome. American Journal of Clinical Nutrition. 1990;52(2):273–279. doi: 10.1093/ajcn/52.2.273. [DOI] [PubMed] [Google Scholar]
  • 42.O'Brien T. E., Ray J. G., Chan W.-S. Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology. 2003;14(3):368–374. doi: 10.1097/00001648-200305000-00020. [DOI] [PubMed] [Google Scholar]
  • 43.James A. H., Jamison M. G., Brancazio L. R., Myers E. R. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetrics & Gynecology. 2006;194(5):1311–1315. doi: 10.1016/j.ajog.2005.11.008. [DOI] [PubMed] [Google Scholar]
  • 44.Maasilta P., Bachour A., Teramo K., Polo O., Laitinen L. A. Sleep-Related Disordered Breathing During Pregnancy in Obese Women. CHEST. 2001;120(5):1448–1454. doi: 10.1378/chest.120.5.1448. [DOI] [PubMed] [Google Scholar]
  • 45.Hendler I., Schatz M., Momirova V., Wise R., Landon M., Mabie W., Newman R. B., Kiley J., Hauth J. C., Moawad A., Caritis S. N., Spong C. Y., Leveno K. J., Miodovnik M., Meis P., Wapner R. J., Paul R. H., Varner M. W., OʼSullivan M. J., Thurnau G. R., Conway D. L. Association of Obesity With Pulmonary and Nonpulmonary Complications of Pregnancy in Asthmatic Women. Obstetrics & Gynecology. 2006;108(1):77–82. doi: 10.1097/01.AOG.0000223180.53113.0f. [DOI] [PubMed] [Google Scholar]
  • 46.Ko C. W., Beresford S. A. A., Schulte S. J., Matsumoto A. M., Lee S. P. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology. 2005;41(2):359–365. doi: 10.1002/hep.20534. [DOI] [PubMed] [Google Scholar]
  • 47.Albert H. B., Godskesen† M., Korsholm L., Westergaard J. G. Risk factors in developing pregnancy-related pelvic girdle pain. Acta Obstetricia et Gynecologica Scandinavica. 2006;85(5):539–544. doi: 10.1080/00016340600578415. [DOI] [PubMed] [Google Scholar]
  • 48.DAlfonso A., Iovenitti P., Carta G. D’Alfonso A. Vol. 33. 33: 23-25; 2006. Urinary disorders during pregnancy and postpartum: our experience. Clin Exp Obstet Gynecol; pp. 23–25. [PubMed] [Google Scholar]

Articles from International Journal of Reproductive Biomedicine are provided here courtesy of Shahid Sadoughi University of Medical Sciences and Health Services

RESOURCES